News zum Sektor Gesundheit aus Israel

Es sind 102 ETFs & Fonds zum Sektor Gesundheit bekannt.

Es sind 1545 Aktien zum Sektor Gesundheit bekannt.

>Gesundheit News Israel
- Top- News
- Alle News
- Branchenanalysen
- Aktienanalysen
- News zum Land A..
  - Afghanistan
  - Afrika
  - Albanien
  - Algerien
  - Angola
  - Argentinien
  - Armenien
  - Aserbaidschan
  - Asien
  - Australien
  - Australien & Ozeanien
- News zum Land B..
  - Bahamas
  - Bahrain
  - Bangladesch
  - Barbados
  - Belgien
  - Belize
  - Benin
  - Bermuda
  - Bhutan
  - Bolivien
  - Bosnien und Herzegowina
  - Botswana
  - Brasilien
  - Britische Jungferninseln
  - Brunei
  - Bulgarien
  - Burkina Faso
  - Burundi
- News zum Land C..
  - Chile
  - China
  - Costa Rica
- News zum Land D..
  - Deutschland
  - Dominikanische Republik
  - Dschibuti
  - Dänemark
- News zum Land E..
  - Ecuador
  - El Salvador
  - Elfenbeinküste
  - Eritrea
  - Estland
  - Europa
- News zum Land F..
  - Fidschi
  - Finnland
  - Frankreich
- News zum Land G..
  - Gabun
  - Gambia
  - Georgien
  - Ghana
  - Griechenland
  - Großbritannien
  - Grönland
  - Guatemala
  - Guinea
  - Guyana
- News zum Land H..
  - Haiti
  - Honduras
  - Hong Kong (China)
- News zum Land I..
  - Indien
  - Indonesien
  - Irak
  - Iran
  - Irland
  - Island
  - Israel
  - Italien
- News zum Land J..
  - Jamaika
  - Japan
  - Jemen
  - Jordanien
- News zum Land K..
  - Kaimaninseln
  - Kambodscha
  - Kamerun
  - Kanada
  - Kasachstan
  - Katar
  - Kenia
  - Kirgisistan
  - Kolumbien
  - Kongo
  - Kosovo
  - Kroatien
  - Kuba
  - Kuwait
- News zum Land L..
  - Laos
  - Lateinamerika
  - Lesotho
  - Lettland
  - Libanon
  - Liberia
  - Libyen
  - Liechtenstein
  - Litauen
  - Luxemburg
- News zum Land M..
  - Madagaskar
  - Malawi
  - Malaysia
  - Mali
  - Marokko
  - Mauretanien
  - Mauritius
  - Mexiko
  - Moldawien
  - Mongolei
  - Montenegro
  - Mosambik
  - Myanmar
- News zum Land N..
  - Naher Osten
  - Namibia
  - Nepal
  - Neuseeland
  - Nicaragua
  - Niederlande
  - Niger
  - Nigeria
  - Nordamerika
  - Nordkorea
  - Nordmazedonien
  - Norwegen
- News zum Land O..
  - Oman
  - Ostblock
  - Osttimor
- News zum Land P..
  - Pakistan
  - Palästina
  - Panama
  - Papua-Neuguinea
  - Paraguay
  - Peru
  - Philippinen
  - Polen
  - Portugal
- News zum Land R..
  - Ruanda
  - Rumänien
  - Russland
- News zum Land S..
  - Sambia
  - Saudi-Arabien
  - Schweden
  - Schweiz
  - Senegal
  - Serbien
  - Sierra Leone
  - Simbabwe
  - Singapur
  - Slowakei
  - Slowenien
  - Somalia
  - Spanien
  - Sri Lanka
  - Sudan
  - Syrien
  - Südafrika
  - Südkorea
- News zum Land T..
  - Tadschikistan
  - Taiwan (China)
  - Tansania
  - Thailand
  - Togo
  - Tschad
  - Tschechien
  - Tunesien
  - Turkmenistan
  - Türkei
- News zum Land U..
  - Uganda
  - Ukraine
  - Ungarn
  - Uruguay
  - USA
  - Usbekistan
- News zum Land V..
  - Venezuela
  - Vereinigte Arabische Emirate
  - Vietnam
- News zum Land W..
  - Weißrussland
- News zum Land Z..
  - Zentralafrikanische Republik
  - Zypern
- News zum Land Ä..
  - Ägypten
  - Äthiopien
- News zum Land Ö..
  - Österreich

12.01.26 - 13:03	MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference (GlobeNewswire EN)
	MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference...

08.01.26 - 14:48	World-Renowned Alzheimer′s Expert Prof. Steven Arnold Joins NeuroSense SAB (PR Newswire)
	Alzheimer's Clinical and Biomarker Outcomes Expected in Q1 2026 CAMBRIDGE, Mass., Jan. 8, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today......

08.01.26 - 13:03	InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M (PR Newswire)
	Conference call to be held on Tuesday, February 10, 2026, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for......

06.01.26 - 18:36	This Fast-Growing Beauty-Tech Stock Is an Unexpected Oddity (Fool)
	Oddity Tech has kept up its momentum since coming public in 2023 and is aiming to revolutionize the beauty industry....

31.12.25 - 21:30	Auch Ärzte ohne Grenzen: Israel droht 37 Hilfsorganisationen mit Zugangsverbot für Gazastreifen (N-TV)
	Die Bevölkerung im in weiten Teilen zerstörten Gazastreifen ist auf die Unterstützung durch Hilfsorganisationen angewiesen. Mehreren Dutzend Organisationen möchte Israel die Lizenz für den Zugang zum Gebiet entziehen. Das Land erhebt schwere Vorwürfe....

23.12.25 - 14:33	Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA′s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation (GlobeNewswire EN)
	FDA qualification of Total Hip BMD as a validated surrogate endpoint for novel osteoporosis drug development further bolsters Entera's July 2025 FDA alignment and regulatory strategy for EB613...

23.12.25 - 13:30	Stocks making the biggest moves premarket: Novo Nordisk, Huntington Ingalls Industries, Zim Integrated Shipping Services & more (CNBC)
	These are the stocks posting the largest moves in premarket trading....

23.12.25 - 05:18	Novo Nordisk, Starfighters Space, D-Wave Quantum, Sidus Space And ZIM Integrated Shipping: Why These 5 Stocks Are On Investors′ Radars Today (Benzinga)
	Major U.S. indexes closed higher on Monday, with the Dow Jones Industrial Average rising 0.47% to 48,362.68. The S&P 500 advanced 0.6% to 6,878.49. read more...

22.12.25 - 16:30	Positive Sicherheitsdaten zu Alzheimer-Medikament treiben NeuroSense-Aktie an (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

22.12.25 - 15:21	NeuroSense Confirms Favorable Safety and Tolerability of PrimeC in an Alzheimer′s Phase 2 Study (PR Newswire)
	Clinical and Biomarker Outcomes Expected to Be Reported in Q1 2026 CAMBRIDGE, Mass., Dec. 22, 2025 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases,......

22.12.25 - 14:36	Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program) (GlobeNewswire EN)
	Novel PTH analog achieves sustained calcium elevation for >3 days from single oral tablet, supporting development path toward once-daily alternative to daily injections Novel PTH analog achieves sustained calcium elevation for >3 days from single oral tablet, supporting development path toward once-daily alternative to daily injections...

17.12.25 - 20:42	Why Is Small Cap Sol-Gel Tech Stock Falling Today? (Benzinga)
	Sol-Gel Technologies ends development of SGT-210 in Darier disease after Phase 1b data show no efficacy versus vehicle. read more...

17.12.25 - 14:27	Sol-Gel halts studies for rare disease therapy after trial setback (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

10.12.25 - 13:03	MediWound Reports New Clinical Data Demonstrating NexoBrid®′s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries (GlobeNewswire EN)
	MediWound Reports New Clinical Data Demonstrating NexoBrid®'s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries...

09.12.25 - 23:33	Amyotrophic Lateral Sclerosis Market Outlook: Expanding Therapeutic Pipeline and Novel Drug Launches Propel Growth Throughout Forecast Period (2025-2034) \| DelveInsight (PR Newswire)
	The amyotrophic lateral sclerosis market is expected to grow owing to the increasing prevalence of the disease, along with the promising emerging pipeline therapies, such as Masitinib (AB Sciences), PrimeC (Neurosense Therapeutics), RNS60 (Revalesio), IFB-088 (InFlectis BioScience), NP001......

08.12.25 - 14:33	Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting (PR Newswire)
	Late Breaking Abstract titled "Targeting SCD1 enhances activity of standard of care regorafenib in hepatocellular carcinoma: translational rationale for a phase 1/2 study of the combination of Aramchol and regorafenib" to be presented with a poster on December 9 at 3pm (HST). RAMAT-GAN,......

07.12.25 - 11:06	No essential supplies in truce: Gaza′s healthcare system broken by Israel (Al Jazeera)
	Israel is not allowing antibiotics, IV solutions or surgical material to enter besieged Gaza despite 2-month ceasefire....

05.12.25 - 14:03

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)

PRINCETON, N.J., Dec. 05, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units (“RSUs”) to 14 new employees in connection with their employment with UroGen. These new team members will support the ongoing commercialization of Jelmyto® (mitomycin) for pyelocalyceal solution and ZUSDURI™ (mitomycin) for intravesical solution, UroGen's only approved products, and the continued development of UroGen's pipeline....

04.12.25 - 15:54	Galmed-Aktie legt nach Patent für MASH-Kombinationstherapie zu (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

04.12.25 - 14:33	Galmed Announces Grant of New Use Patents for the combination of Aramchol and Madrigal Pharmaceuticals′ Rezdiffra (Resmetirom) for MASH (PR Newswire)
	The new patent granted in South Korea is added to earlier patents already granted by the United States Patent and Trademark Office (USPTO), Europe, Canada and other jurisdictions and will expire in the U.S. in July 2042. Aramchol is a first-in-class, Phase 3 ready, drug candidate, that......

>weitere News anzeigen...